Sponsor

Neurim Pharmaceuticals (1991) Ltd.

27 Habarzel, 6971039

About the sponsor

Research activity is centered on sleep disorders, with a specific focus on idiopathic Rapid Eye Movement Behavior Disorder and related disturbances of sleep architecture and nocturnal motor control.

Rapid Eye Movement Behavior Disorder
Sleep laboratory evaluation

The sponsor’s clinical interest in this area reflects work aimed at understanding and addressing abnormal behaviors occurring during REM sleep.

About Specializations

Neurim Pharmaceuticals (1991) Ltd. runs clinical trials in conditions such as Rapid eye movement sleep behaviour disorder, among others.

Rapid eye movement sleep behaviour disorder

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

Rapid eye movement sleep behaviour disorder

Not recruiting

InvestigationalNo placebo

Study on the Effects and Safety of Piromelatine for Patients with Idiopathic Rapid Eye Movement Behavior Disorder (iRBD)

InvestigationalNo placebo

Austria

Participants:18–64 years · 65+ years
Substances:Piromelatine
Sponsor:Neurim Pharmaceuticals (1991) Ltd.

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →